DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Pappas Ventures Names Eric Linsley Managing Partner
News | 09. 28. 2009
Pappas Ventures today announced that Eric W. Linsley has been promoted to Managing Partner.
